Carrick Therapeutics lands $35m investment from Pfizer

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 71%

Sverige Nyheter Nyheter

Sverige Senaste nytt,Sverige Rubriker

Dublin-based biopharma firm has received investment to support the rapid development of its flagship drug samuraciclib which is used in the treatment of HR+, HER2- breast cancer

Carrick Therapeutics, a Dublin-headquartered biopharma firm, has landed a $35 million investment from Pfizer as it also confirmed the final closure of a $25 million Series C funding round.

The company which is developing pioneering treatments to defeat some of the most aggressive cancers was founded by Elaine Sullivan, a former vice-president for research and development at both Eli Lilly and AstraZeneca, in 2016.

 

Tack för din kommentar. Din kommentar kommer att publiceras efter att ha granskats.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer:

 /  🏆 8. in SE

Sverige Senaste nytt, Sverige Rubriker